Table 2.
Study | Place of measurement | Time period of measurement | Pharmacokinetic findings | Infection control |
---|---|---|---|---|
Anagnostakos et al. [6] | Joint fluid | First 7 postop. days | [G]MAX 39 µg/ml, [V]MAX 72 µg/ml on day 1 [G]MIN 1.9 µg/ml, [V]MIN 6.6 µg/ml on day 7 Between days 5 and 7 intermittent increase in the elution of both antibiotics |
n.r. |
| ||||
Balato et al. [7] | Joint fluid | First 48 postop. hours | [G]MAX 53.9 µg/ml in the hip group, [G]MAX 44.1 µg/ml in the knee group Mean [G] significantly higher in the hip than in the knee group (30.61 ± 19.47 µg/ml versus 17.43 ± 13.63 µg/ml) one hour after implantation |
100% |
| ||||
Bertazzoni Minelli et al. [8] | Joint fluid | First 24 postop. hours | [G]MAX 88 µg/ml in the hip group, [G]MAX 110 µg/ml in the knee group [V]MAX 28.8 µg/ml in the hip group, [V]MAX 158.9 µg/ml in the knee group |
100% |
| ||||
Hsieh et al. [10] | Joint fluid | First 7 postop. days | Mean [V]MAX 1,538 µg/ml, mean [A]MAX 1,003.5 µg/ml on day 1 Mean [V]MIN 571.9 µg/ml, mean [A]MIN 313.6 µg/ml on day 7 |
97.8% |
| ||||
Hsieh et al. [11] | Joint fluid | First 7 postop. days | Mean [G]MAX 58.3 µg/ml, mean [V]MAX 485.5 µg/ml on day 1 Mean [G]MIN 14.6 µg/ml, mean [V]MIN 76.1 µg/ml on day 7 |
95.2% |
| ||||
Isiklar et al. [12] | Joint fluid | First 24 postop. hours | Mean [V] 57 [32–81] µg/ml | 100% |
| ||||
Kelm et al. [13] | Joint fluid | First 7 postop. days | Vancomycin quantitatively higher than gentamicin extrapolated concentration-time curves showed power functions, so that subtherapeutic antibiotic levels can be expected for vancomycin on the 17th postop. day and for gentamicin on the 14th postop. day |
n.r. |
| ||||
Regis et al. [16] | Joint fluid | First 24 postop. hours | [G] ranged between 15 and 90 µg/ml; [V] ranged between 13.8 and 40 µg/ml | n.r. |
G: gentamicin; V: vancomycin; A: aztreonam; MAX: maximum; MIN: minimum; n.r.: not reported.